Skip to main content
Top
Published in: European Radiology 6/2019

01-06-2019 | Musculoskeletal

Accuracy of iodine density thresholds for the separation of vertebral bone metastases from healthy-appearing trabecular bone in spectral detector computed tomography

Authors: Jan Borggrefe, Victor-Frederic Neuhaus, Markus Le Blanc, Nils Grosse Hokamp, Volker Maus, Anastasios Mpotsaris, Simon Lennartz, Daniel Pinto dos Santos, David Maintz, Nuran Abdullayev

Published in: European Radiology | Issue 6/2019

Login to get access

Abstract

Purpose

To evaluate quantitative iodine density mapping (IDM) with spectral detector computed tomography (SDCT) as a quantitative biomarker for separation of vertebral trabecular bone metastases (BM) from healthy-appearing trabecular bone (HTB).

Materials and methods

IRB-approved retrospective single-center-study of portal venous SDCT datasets acquired between June 2016 and March 2017. Inclusion of 43 consecutive cancer patients with BM and 40 without. Target lesions and non-affected control vertebrae were defined using follow-up imaging, MRI, and/or bone scintigraphy. ID and standard deviation were determined with ROI measures by two readers in (a) bone metastases, (b) HTB of BM patients and controls, and (c) ID of various vessels. Volumetric bone mineral density (vBMD) of the lumbar spine and age were recorded. Multivariate ROC analyses und Wilcoxon test were used to determine thresholds for separation of BM and HTB. p < 0.05 was considered significant.

Results

ID measurements of 40 target lesions and 83 reference measurements of HTB were acquired. Age (p < 0.0001) and vBMD (p < 0.05) affected ID measurements independently in multivariate models. There were significant differences of ID between metastases (n = 43) and HTB ID (n = 124; mean 5.5 ± 0.9 vs. 3.5 ± 0.9; p < 0.0001), however, with considerable overlap. In univariate analysis, increased ID discriminated bone lesions (AUC 0.90) with a maximum combined specificity/sensitivity of 77.5%/90.7% when applying a threshold of 4.5 mg/ml. Multivariate regression models improved significantly when considering vBMD, the noise of ID, and vertebral venous ID (AUC 0.98).

Conclusion

IDM of SDCT yielded a statistical separation of vertebral bone lesions and HTB. Adjustment for confounders such as age and lumbar vBMD as well as for vertebral venous ID and lesion heterogeneity improved discrimination of trabecular lesions.

Key Points

• SDCT iodine density mapping provides the possibility for quantitative analysis of iodine uptake in tissue, which allows to differentiate bone lesions from healthy bone marrow.
• Age and vBMD have a significant impact on iodine density measurements.
• Iodine density measured in SDCT yielded highest sensitivity and specificity for the statistical differentiation of vertebral trabecular metastases and healthy trabecular bone using an iodine density threshold of 4.5 mg/ml (most performant)–5.0 mg/ml (optimized for specificity).
Appendix
Available only for authorised users
Literature
1.
go back to reference White AP, Kwon BK, Lindskog DM, Friedlaender GE, Grauer JN (2006) Metastatic disease of the spine. J Am Acad Orthop Surg 14:587–598 White AP, Kwon BK, Lindskog DM, Friedlaender GE, Grauer JN (2006) Metastatic disease of the spine. J Am Acad Orthop Surg 14:587–598
2.
go back to reference Guillevin R, Vallee JN, Lafitte F, Menuel C, Duverneuil NM, Chiras J (2007) Spine metastasis imaging: review of the literature. J Neuroradiol 34:311–321 Guillevin R, Vallee JN, Lafitte F, Menuel C, Duverneuil NM, Chiras J (2007) Spine metastasis imaging: review of the literature. J Neuroradiol 34:311–321
8.
go back to reference Rybak LD, Rosenthal DI (2001) Radiological imaging for the diagnosis of bone metastases. Q J Nucl Med 45:53–64PubMed Rybak LD, Rosenthal DI (2001) Radiological imaging for the diagnosis of bone metastases. Q J Nucl Med 45:53–64PubMed
18.
20.
go back to reference Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR (1995) Vascular permeability factor/ vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107:233–235. https://doi.org/10.1159/000236988 Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR (1995) Vascular permeability factor/ vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107:233–235. https://​doi.​org/​10.​1159/​000236988
21.
go back to reference Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49:6449–6465PubMed Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49:6449–6465PubMed
30.
go back to reference Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–7CrossRefPubMed Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–7CrossRefPubMed
Metadata
Title
Accuracy of iodine density thresholds for the separation of vertebral bone metastases from healthy-appearing trabecular bone in spectral detector computed tomography
Authors
Jan Borggrefe
Victor-Frederic Neuhaus
Markus Le Blanc
Nils Grosse Hokamp
Volker Maus
Anastasios Mpotsaris
Simon Lennartz
Daniel Pinto dos Santos
David Maintz
Nuran Abdullayev
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 6/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5843-y

Other articles of this Issue 6/2019

European Radiology 6/2019 Go to the issue